Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
5
United States Gasoline Fund Lp
UGA
US Stock MarketDetailed Quotes
Lexeo Therapeutics (LXEO)
- 5.780
- +0.060+1.05%
Trading Mar 26 14:17 ET
421.86MMarket Cap-2.31P/E (TTM)
6.080High5.560Low396.89KVolume5.620Open5.720Prev Close2.31MTurnover0.86%Turnover RatioLossP/E (Static)72.99MShares10.99052wk High3.49P/B265.68MFloat Cap1.45052wk Low--Dividend TTM45.97MShs Float22.330Historical High--Div Yield TTM9.09%Range %1.450Historical Low5.832Avg Price1Lot Size
Lexeo Therapeutics (LXEO) Key Financial Indicators
LXEO Earnings per Share (EPS)
According to the latest financial report of Lexeo Therapeutics, the latest earnings per share (TTM) for the company is -0.33. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
LXEO Free Cash Flow (FCF)
Interested in knowing about Lexeo Therapeutics's free cash flow? The latest report shows it as -29.84M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
LXEO Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Lexeo Therapeutics shows that the company's current ratio is 7.40, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
LXEO Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Lexeo Therapeutics, the quick ratio is 7.11, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
LXEO Return on Equity (ROE)
Want to learn more about the financial health of Lexeo Therapeutics? The latest ROE figure is -15.66%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
LXEO Return on Assets (ROA)
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Lexeo Therapeutics, the total asset return on investment (ROA) is -12.68%.
Currency: USD
Quarterly
Loading...
LXEO Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Lexeo Therapeutics's latest financial report to see how their gross margin is doing - currently at --.
Currency: USD
Quarterly
Loading...
LXEO Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Lexeo Therapeutics, the net profit margin is -3.21K%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Market Insights
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
Recently, the prospects of a ceasefire negotiation between the US and Iran have been dominating market sentiment. On March 26, Eastern Time,
富哥搞钱
Feb 28 17:22
Breaking! The US and Israel jointly bombed Iran. What will be the stock market trend next week?
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.